Issuer · CIK 0001855175
CTNM — Contineum Therapeutics, Inc.
Recent filings
- Jun 1, 2026·Form 4·Sell$54.9K
CTNM/Contineum Therapeutics, Inc.
Lorrain Daniel S. · Chief Scientific Officer
Mechanical filing
AI thesis skipped - Mar 2, 2026·Form 4·Sell$62.6K
CTNM/Contineum Therapeutics, Inc.
Lorrain Daniel S. · Chief Scientific Officer
28conviction - Feb 13, 2026·Form 4·Sell$6.4K
CTNM/Contineum Therapeutics, Inc.
Lorrain Daniel S. · Chief Scientific Officer
8conviction